Emory University;The Board of Regents of the University of Texas System
发明人:
Xingming Deng,Jia Zhou,Chunyong Ding
申请号:
US15309382
公开号:
US09980936B2
申请日:
2015.05.05
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.